FDA approves ensartinib for ALK-positive locally advanced or metastatic non-small cell lung cancer

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-ensartinib-alk-positive-locally-advanced-or-metastatic-non-small-cell-lung-cancer